BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2018
View Archived Issues
Inhibitor of alphavbeta6 integrin prevents pre-established biliary fibrosis in BALBc.Mdr2-/- mice
Read More
Pulmonary delivery of mRNA encoding antibodies protects mice from RSV infection
Read More
MCR1-targeting PET and fluorescence imaging probes for melanoma developed
Read More
Mutant c-KIT inhibitor AZD-3229 is equivalent or superior to existing inhibitors in GISTs
Read More
Newly identified cell type precedes mast cells in anaphylaxis cascade
Read More
RetiPharma secures funding to prepare RP-001 for proof-of-concept study in retinal detachment
Read More
Hemostemix develops ACP-01 allogeneic process, begins R&D for NCP-01
Read More
Clinical data presented for JNJ-64530440, a novel HBV capsid-assembly modulator, in healthy subjects
Read More
MSC-derived EVs reduce inflammatory response and scarring after traumatic spinal cord injury in rats
Read More
AN-317, a drug candidate for PD, demonstrates efficacy in vivo
Read More
China SFDA clears phase I trial of A-319 in B-cell malignancies
Read More
Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata
Read More
Results from phase IIa study of Zimura plus Lucentis in wet AMD
Read More
Swedish Medical Products Agency allows initiation of phase I trial of ROSgard
Read More
KalVista designs enlarged phase II study for KVD-900 in HAE
Read More
Exploratory clinical studies of NYX-2925 show NMDAr-mediated pharmacodynamic activity
Read More
FDA clears PolyPid to begin phase III study of D-PLEX[100]
Read More
QBiotics reports first-in-human data for tigilanol tiglate in solid tumors
Read More
Effects of tenofovir and tenofovir/levonorgestrel vaginal rings on vaginal microbiota and mucosal PK
Read More
Novel rBCG:HIV vaccine candidates with a ChAd.HIV boost show safety and immunogenicity in vivo
Read More
sFRP3 as a novel therapeutic target in Alzheimer's disease
Read More
Novel HBV capsid formation inhibitor, CB-HBV-001, demonstrates promising safety and PK in vivo
Read More
First patient enrolled in phase IIa ALICE study of iadademstat in AML
Read More
Nightstar Therapeutics updates status of NSR-RPGR program in X-linked retinitis pigmentosa
Read More
Sutro plans phase I trial of STRO-002 following FDA conclusion of IND review
Read More
